Ligand Pharmaceuticals reported $26.05M in Trade Creditors for its fiscal quarter ending in June of 2025.


Trade Creditors Change Date
Amgen USD 18.03B 15.63B Jun/2025
Arrowhead Research USD 33.05M 23.07M Jun/2025
Baxter International USD 963M 5M Mar/2025
Bristol-Myers Squibb USD 5.43B 1.42B Jun/2025
Eli Lilly USD 4.08B 633.7M Jun/2025
Gilead Sciences USD 582M 155M Jun/2025
GlaxoSmithKline 14.82B 329M Jun/2025
Glaxosmithkline 13.65B 10.19B Jun/2025
Insmed USD 78.35M 16.95M Jun/2025
Ionis Pharmaceuticals USD 22.8M 5.34M Jun/2025
Ligand Pharmaceuticals USD 26.05M 20.68M Jun/2025
MacroGenics USD 4.66M 353K Jun/2025
Merck USD 4.04B 261M Jun/2025
Pacira USD 30.12M 6.95M Jun/2025
Pfizer USD 5.17B 74M Jun/2025
Veracyte USD 11.45M 4.26M Jun/2025